Gestational diabetes
Gestational diabetes mellitus (GDM) is glucose intolerance or diabetes first recognized during pregnancy.
Gestational diabetes mellitus (GDM) is glucose intolerance or diabetes first recognized during pregnancy. It develops when the normal pregnancy-related increase in insulin resistance—driven in part by placental and other hormonal changes—exceeds the pancreatic β-cell capacity to produce insulin, resulting in elevated maternal blood glucose. Risk is influenced by factors including maternal age, body mass index, obesity, previous GDM, and susceptibility to type 2 diabetes. GDM is clinically important because it is associated with adverse pregnancy outcomes, including hypertensive disorders such as pre-eclampsia, and identifies increased longer-term risk of metabolic disease in the mother. Diagnosis generally relies on antenatal glucose testing, including an oral glucose tolerance test, according to locally adopted screening guidelines.
Current research emphasizes earlier and more individualized risk assessment. Studies are evaluating composite prediction tools and machine learning approaches based on clinical characteristics, metabolic and lipid measures, inflammatory indices, metabolites and gut microbiota, and first-trimester placental texture. Reproductive factors such as delayed childbearing, low fertility, and menstrual cycle length, as well as recurrence across pregnancies, are being investigated as risk modifiers. The potential relationship between preconception GLP-1 receptor agonist or tirzepatide exposure and subsequent GDM risk is also an emerging area of study; validation across populations and integration with routine screening remain important challenges.
Where the papers sit
10 papers from the last 6 months study gestational diabetes directly · updated from PubMed 4 Nov 2026
Study type 0 clinical trials · 7 observational · 3 human data
Themes 3 themes · 1 new direction
-
Metabolic Risk Prediction
Gestational diabetes prediction is moving toward models that combine obesity, lipid metabolism, reproductive history, microbiota-related metabolites, and prior disease. Body mass index, overweight status, triglycerides, menstrual cycle length, and recurrence provide recurring clinical risk signals. Three-metabolite signatures and composite tools are being developed for early stratification and prediction of hypertensive disorders. Temporal validation supports broader testing, but applicability across populations and transfer from prediction to prevention remain open.
5 papers · 50%
-
Maternal Risk and Screening
Delayed childbearing, sleep impairment, and screening access are being linked to gestational diabetes risk. Maternal age and low fertility are examined as independent and combined risk factors, while sleep duration and quality distinguish disease subtypes. Glucose tolerance testing remains the clinical anchor, with hospital audits highlighting adherence gaps. The work is moving toward earlier risk recognition alongside more reliable implementation of screening guidelines.
3 papers · 30%
-
Periodontal Inflammation in Pregnancy
Periodontal inflammation and blood-based inflammatory indices are being examined as markers associated with gestational diabetes. Bleeding on probing and periodontal disease recur alongside MMP9, matrix metallopeptidase 8, and Tnf measurements. Novel composite indices and logistic regression aim to improve early risk assessment beyond conventional metabolic variables. The evidence remains associative, leaving the direction of causality and clinical utility unresolved.
2 papers · 20%
Gestational diabetes is treated as a health-system screening-implementation problem
The Ethiopian three-hospital audit of gestational-diabetes screening 42640935Aug treats GDM not as a biological outcome, risk state, biomarker target, or prognostic endpoint—as in the other abstracts—but as a condition whose detection must be evaluated against guideline-concordant antenatal care. By examining screening uptake, timing, methods, and documented diagnosis in routine practice, it shifts the focus from predicting or explaining GDM to assessing whether health services are delivering the recommended process for finding it.
Papers
The 10 papers from the last 6 months that study gestational diabetes directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Metabolic Risk Prediction (5)
- Association of third-trimester maternal lipid levels with adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective single-center study using intrapartum data. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 28 Oct 2026 PMID 42951837
- A composite tool for predicting gestational diabetes or hypertensive disorders of pregnancy: development and temporal validation. Computers in biology and medicine · 11 Sept 2026 PMID 42727299
- Associations of menstrual cycle length with GDM and gestational hypertension in frozen embryo transfer. Journal of ovarian research · 4 Sept 2026 PMID 42693441
- A three-metabolite microbiota-associated signature for early risk stratification of gestational diabetes mellitus. Cardiovascular diabetology · 7 Aug 2026 PMID 42568080
- Prevalence and recurrence rate of gestational diabetes: A nationwide cohort study. European journal of obstetrics, gynecology, and reproductive biology · 13 Jun 2026 PMID 42287869
Maternal Risk and Screening (3)
- Association between sleep impairment and gestational diabetes mellitus subtypes: A prospective cohort study. Sleep & breathing = Schlaf & Atmung · 9 Oct 2026 PMID 42853357
- Adherence to gestational diabetes screening guidelines: Retrospective audit in three public hospitals in Ethiopia. PloS one · 25 Aug 2026 PMID 42640935
- Low fertility and delayed childbearing: Independent and combined effects on gestational diabetes risk in high-income women. Diabetes research and clinical practice · 22 Aug 2026 PMID 42632458
Periodontal Inflammation in Pregnancy (2)
- Association between gestational diabetes mellitus and periodontal inflammation in a South African cohort. Clinical oral investigations · 10 Oct 2026 PMID 42858193
- Novel Hematological Inflammatory Indices in Early Pregnancy: The Predictive Value of the Cumulative Inflammatory Index and Mean Corpuscular Volume/Lymphocyte for Gestational Diabetes Mellitus. American journal of reproductive immunology (New York, N.Y. : 1989) · 1 Jun 2026 PMID 42223168
By study type
Observational studies and case reports (7)
- Association of third-trimester maternal lipid levels with adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective single-center study using intrapartum data. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 28 Oct 2026 PMID 42951837
- Association between gestational diabetes mellitus and periodontal inflammation in a South African cohort. Clinical oral investigations · 10 Oct 2026 PMID 42858193
- Association between sleep impairment and gestational diabetes mellitus subtypes: A prospective cohort study. Sleep & breathing = Schlaf & Atmung · 9 Oct 2026 PMID 42853357
- Adherence to gestational diabetes screening guidelines: Retrospective audit in three public hospitals in Ethiopia. PloS one · 25 Aug 2026 PMID 42640935
- A three-metabolite microbiota-associated signature for early risk stratification of gestational diabetes mellitus. Cardiovascular diabetology · 7 Aug 2026 PMID 42568080
- Prevalence and recurrence rate of gestational diabetes: A nationwide cohort study. European journal of obstetrics, gynecology, and reproductive biology · 13 Jun 2026 PMID 42287869
- Novel Hematological Inflammatory Indices in Early Pregnancy: The Predictive Value of the Cumulative Inflammatory Index and Mean Corpuscular Volume/Lymphocyte for Gestational Diabetes Mellitus. American journal of reproductive immunology (New York, N.Y. : 1989) · 1 Jun 2026 PMID 42223168
Human data, design not indexed (3)
- A composite tool for predicting gestational diabetes or hypertensive disorders of pregnancy: development and temporal validation. Computers in biology and medicine · 11 Sept 2026 PMID 42727299
- Associations of menstrual cycle length with GDM and gestational hypertension in frozen embryo transfer. Journal of ovarian research · 4 Sept 2026 PMID 42693441
- Low fertility and delayed childbearing: Independent and combined effects on gestational diabetes risk in high-income women. Diabetes research and clinical practice · 22 Aug 2026 PMID 42632458
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-10-02. Drafted by language models from published abstracts; not medical advice.